Achilles Therapeutics plc (ACHL)

NASDAQ: ACHL · IEX Real-Time Price · USD

0.783

-0.017 (-2.16%)

At close: Apr 19, 2024, 3:56 PM

0.800

+0.017 (2.15%)

After-hours: Apr 19, 2024, 6:16 PM EDT

Achilles Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	17.01	21.12	21.97	11.1	4.7
Research & Development	58.25	57.26	42.22	22.63	9.07
Operating Expenses	75.26	78.38	64.2	33.73	13.78
Operating Income	-75.26	-78.38	-64.2	-33.73	-13.78
Other Expense / Income	-6.08	-7.32	-3.13	-0.53	0.22
Pretax Income	-69.17	-71.07	-61.06	-33.2	-13.99
Income Tax	0.49	0.11	0.04	0	0
Net Income	-69.67	-71.18	-61.1	-33.2	-13.99
Shares Outstanding (Basic)	40	39	29	1	1
Shares Outstanding (Diluted)	40	39	29	1	1
Shares Change	2.13%	36.59%	2587.54%	66.03%	-
EPS (Basic)	-1.74	-1.82	-2.13	-31.14	-21.79
EPS (Diluted)	-1.74	-1.82	-2.13	-31.14	-21.79
Free Cash Flow	-49.55	-67.05	-66.92	-37.1	-15.08
Free Cash Flow Per Share	-1.24	-1.71	-2.33	-34.80	-23.49
EBITDA	-64.46	-67.38	-57.77	-32.42	-13.69
Depreciation & Amortization	4.71	3.69	3.29	0.77	0.3
EBIT	-69.17	-71.07	-61.06	-33.2	-13.99

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).